首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis, molecular structure, and in vitro antitumor activity of new 4-chloro-2-mercaptobenzenesulfonamide derivatives.
【24h】

Synthesis, molecular structure, and in vitro antitumor activity of new 4-chloro-2-mercaptobenzenesulfonamide derivatives.

机译:新的4-氯-2-巯基苯磺酰胺衍生物的合成,分子结构和体外抗肿瘤活性。

获取原文
获取原文并翻译 | 示例
           

摘要

The reaction of 3-amino-2-(2-alkylthio-4-chlorobenzenesulfonyl)guanidines 2a-j with 1,2-dicarbonyl compounds are described. Depending on structure of 1,2-dicarbonyl reagent novel 2-alkylthio-5-chloro-N-(1,2,4-triazin-3-yl)benzenesulfonamides 3-15, 1-(2-alkylthio-4-chlorobenzenesulfonyl)-3-(2-oxobutane-3-ylidenoimino)guan idines 16-18 and 2-alkylthio-4-chloro-N-(1,2-dihydroxycyclobuta[e]1,2,4-triazin-3-yl)benzen esulfonamides 19-21 are obtained. The structures of these compounds were confirmed on the basis of elemental analysis, spectral data and X-ray analysis. The compounds 4, 5, 7, 9, 10, 12-15, 17, 18 and 20 were screened at the National Cancer Institute (NCI) for their in vitro activities against a panel of 56 tumor cell lines and relationship between structure and antitumor activity are discussed. The compounds 10, 12, 17 and 20 were inactive, whereas the other compounds exhibited reasonable activity against one or more human tumor cell lines. The prominent compound 18 showed significant activity against cell lines of colon cancer (HCT-116), renal cancer (786-0) and melanoma (M14) (GI(50) in the range 0.33-1.08 muM) as well as good selectivity toward non-small cell lung cancer (HOP-62) cells (GI(50) = 0.05 muM, TGI = 0.38 muM and LC(50) = 4.83 muM).
机译:描述了3-氨基-2-(2-烷硫基-4-氯苯磺酰基)胍2a-j与1,2-二羰基化合物的反应。取决于1,2-二羰基试剂的结构,新型2-烷硫基5-氯-N-(1,2,4-三嗪-3-基)苯磺酰胺3-15,1-(2-烷硫基-4-氯苯磺酰基) -3-(2-氧代丁烷-3-yylnoimino)胍16-18和2-烷硫基-4-氯-N-(1,2-二羟基环丁[e] 1,2,4-三嗪-3-基)苯获得了磺酰胺19-21。这些化合物的结构根据元素分析,光谱数据和X射线分析确定。在美国国家癌症研究所(NCI)筛选了化合物4、5、7、9、10、12-15、17、18和20,它们对56种肿瘤细胞系的体外活性以及结构与抗肿瘤的关系活动进行了讨论。化合物10、12、17和20没有活性,而其他化合物对一种或多种人类肿瘤细胞系表现出合理的活性。著名的化合物18对结肠癌(HCT-116),肾癌(786-0)和黑素瘤(M14)(GI(50)在0.33-1.08μM范围内)的细胞系表现出显着活性,并且对非小细胞肺癌(HOP-62)细胞(GI(50)= 0.05μM,TGI = 0.38μM和LC(50)= 4.83μM)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号